Netherlands· NL-bc94f3705c86
BOTOX, 100 Allerganeenheden, poeder voor oplossing voor injectie
A botulinus toxin product containing botulinum toxine, type a, registered in Netherlands by EU-Pharma B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Botulinus toxin is registered in 11 of 19 countries.
Countries holding a registration under ATC M03AX01 (botulinus toxin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Botulinus toxin · ATC M03AX01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BOTULINUM TOXINE, Type A
- Manufacturer
- EU-Pharma B.V.
- Country
- Netherlands (NL)
- ATC code
- M03AX01
- ATC class
- Botulinus Toxin
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id132929//117146
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for botulinus toxin.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Botulinus toxin · interactions on record
55 records
- 11 severe
- 44 moderate
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- KanamycinA07AA08severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under M03AX01
Botulinus toxin, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b77ef77f-616a-43b4-bcdf-2f15da39a095 GET /v1/drugs/b77ef77f-616a-43b4-bcdf-2f15da39a095?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor oplossing voor injectie",
"route": "Intramusculair gebruik, Intradermaal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h117146_smpc.pdf",
"strength": null,
"atc_label": "Botulinum Toxin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132929",
"excipients": [
"HUMAAN ALBUMINE OPLOSSING",
"NATRIUMCHLORIDE"
],
"substances": [
"BOTULINUM TOXINE, Type A"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132929.pdf",
"authorised_at": "2024/03/19",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "132929//117146",
"additional_monitoring": "N"
}See everything about botulinus toxin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.